[Disclosure] SAMSUNG BIOLOGICS(207940) Amends Public Filing to Official Wording ‘Appeal Dismissed (Not Guilty)’ Upon Receiving Appellate Court’s Written Judgment

Fact Source: Financial Supervisory Service DART / 2025-02-04

Disclosure Type: Measures Following Violations of Accounting Standards (Amendment)

💡 3-Second Summary

SAMSUNG BIOLOGICS has officially amended its public disclosure to reflect the exact legal wording of “Appeal Dismissed (Not Guilty)” after receiving the written judgment from the appellate court regarding past alleged accounting rule violations.

📊 1. [Key Disclosure Content & Major Figures Summary]

• Reason for Amendment: Correction of specific disclosure items following the official receipt of the second-instance appellate court’s written judgment.
• Amendments Made (Data Integrity Verification):
  • Core Violation Content Item: (Before Amendment) No Violation Detected ➔ (After Amendment) Appeal Dismissed (Not Guilty)
  • Other Important Investment Considerations: The temporary notation stating ‘filing will be amended after written judgment is received’ has been deleted.
• Final Ruling Result: Not Guilty (Determined by the Seoul High Court)
• Competent Jurisdiction: Seoul High Court (Second-Instance Appellate Court)
• Key Legal Timeline:
  • Date of Second-Instance Verdict/Decision: February 3, 2025
  • Date of Corporate Confirmation & Initial Filing: February 3, 2025
  • Date of Amending Report Submission: February 4, 2025
• Countermeasures: The company intends to take necessary measures, including enhancing accounting transparency and strengthening internal monitoring controls.
• Regulatory Caveat: This disclosure is based on the ruling of the second-instance appellate court and remains subject to potential changes depending on future appeals and the corresponding final Supreme Court decision.

📈 2. [Expert Insight: What This Disclosure Means for Investors]

This amendment filing serves as an administrative update that directly reflects the exact wording of the appellate court’s written judgment after it was received by the company, ensuring formal alignment within the public registry.

The critical takeaway for international market participants is the formal entry of the phrase “Appeal Dismissed (Not Guilty)” into the regulatory disclosure system. Replacing the preliminary description of “No Violation Detected” with the court’s official language ensures data integrity. The document contains zero revisions to immediate balance sheet metrics, ongoing production facility operations, or CAPEX outlays.

As explicitly noted in the disclosure, the case remains subject to any future appeal and subsequent court rulings. Therefore, the final resolution of this governance matter continues to depend on whether further legal actions are initiated. Because the legal proceedings remain ongoing pending any further judicial process, investors should track subsequent official filings while focusing primarily on core operational and financial metrics.

📝 Editor’s Comment (by K-STOCK Editor)

SAMSUNG BIOLOGICS has updated its public ledger to align with the formal documentation received from the judiciary. By changing the general description to the official legal term “Appeal Dismissed (Not Guilty),” the company has synchronized its corporate filing with the precise text of the written judgment.

For global investors, this amendment constitutes a procedural update rather than a new operational driver or financial metric. Its significance is limited to the formal entry of the appellate court’s finalized wording into the DART system. As stated in the regulatory notice, the matter may still change depending on potential future appeals and subsequent rulings, meaning that the legal proceedings remain ongoing pending any further judicial process. Investors are advised to maintain an objective perspective based strictly on verified corporate announcements while final judicial paths remain open.

📢 Disclaimer and Source Information

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.